Asfaha S, Cenac N, Houle S, Altier C, Papez M D, Nguyen C, Steinhoff M, Chapman K, Zamponi G W, Vergnolle N
Mucosal Inflammation Research Group, Department of Pharmacology and Therapeutics, University of Calgary, Calgary, Alberta, Canada.
Br J Pharmacol. 2007 Jan;150(2):176-85. doi: 10.1038/sj.bjp.0706975. Epub 2006 Dec 18.
Protease-activated receptor-4 (PAR(4)), the most recently discovered member of the PARs family, is activated by thrombin, trypsin and cathepsin G, but can also be selectively activated by small synthetic peptides (PAR(4)-activating peptide, PAR(4)-AP). PAR(4) is considered a potent mediator of platelet activation and inflammation. As both PAR(1) and PAR(2) have been implicated in the modulation of nociceptive mechanisms, we investigated the expression of PAR(4) in sensory neurons and the effects of its selective activation on nociception.
We demonstrated the expression of PAR(4) in sensory neurons isolated from rat dorsal root ganglia by reverse transcription-polymerase chain reaction and immunofluorescence. We found that PAR(4) colocalized with calcitonin gene-related peptide and substance P. We also showed that a selective PAR(4)-AP was able to inhibit calcium mobilization evoked by KCl and capsaicin in rat sensory neurons. Moreover, the intraplantar injection of a PAR(4)-AP significantly increased nociceptive threshold in response to thermal and mechanical noxious stimuli, while a PAR(4) inactive control peptide had no effect. The anti-nociceptive effects of the PAR(4)-AP were dose-dependent and occurred at doses below the threshold needed to cause inflammation. Finally, co-injection of the PAR(4)-AP with carrageenan significantly reduced the carrageenan-induced inflammatory hyperalgesia and allodynia, but had no effect on inflammatory parameters such as oedema and granulocyte infiltration.
Taken together, these results identified PAR(4) as a novel potential endogenous analgesic factor, which can modulate nociceptive responses in normal and inflammatory conditions.
蛋白酶激活受体 - 4(PAR(4))是PARs家族中最新发现的成员,可被凝血酶、胰蛋白酶和组织蛋白酶G激活,但也可被小的合成肽(PAR(4)激活肽,PAR(4)-AP)选择性激活。PAR(4)被认为是血小板激活和炎症的强效介质。由于PAR(1)和PAR(2)都与伤害性感受机制的调节有关,我们研究了PAR(4)在感觉神经元中的表达及其选择性激活对伤害感受的影响。
我们通过逆转录 - 聚合酶链反应和免疫荧光证明了PAR(4)在从大鼠背根神经节分离的感觉神经元中的表达。我们发现PAR(4)与降钙素基因相关肽和P物质共定位。我们还表明,选择性PAR(4)-AP能够抑制氯化钾和辣椒素在大鼠感觉神经元中诱发的钙动员。此外,足底注射PAR(4)-AP可显著提高对热和机械性有害刺激的伤害感受阈值,而PAR(4)无活性对照肽则无作用。PAR(4)-AP的抗伤害感受作用呈剂量依赖性,且在引起炎症所需阈值以下的剂量时就会出现。最后,将PAR(4)-AP与角叉菜胶共同注射可显著减轻角叉菜胶诱导的炎症性痛觉过敏和异常性疼痛,但对水肿和粒细胞浸润等炎症参数无影响。
综上所述,这些结果确定PAR(4)为一种新型潜在内源性镇痛因子,它可在正常和炎症条件下调节伤害感受反应。